Cytokinetics
CYTK
CYTK
132 hedge funds and large institutions have $575M invested in Cytokinetics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 136 → 132 (-4)
4.93% less ownership
Funds ownership: 78.84% → 73.92% (-4.9%)
Holders
132
Holding in Top 10
–
Calls
$9.37M
Puts
$6.62M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$14.6M | |
| 3 | +$8.66M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.17M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.92M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.32M | |
| 3 | -$4.96M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.57M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$3.93M |